CSURE-M Stock Overview
Cannassure Therapeutics Ltd cultivates and produces medical cannabis.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Cannassure Therapeutics Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪11.20 |
| 52 Week High | ₪13.27 |
| 52 Week Low | ₪2.91 |
| Beta | 0.25 |
| 1 Month Change | 42.06% |
| 3 Month Change | 123.55% |
| 1 Year Change | 164.15% |
| 3 Year Change | -86.00% |
| 5 Year Change | -95.61% |
| Change since IPO | -96.03% |
Recent News & Updates
Recent updates
Shareholder Returns
| CSURE-M | IL Pharmaceuticals | IL Market | |
|---|---|---|---|
| 7D | -1.1% | -2.9% | -0.7% |
| 1Y | 164.2% | -17.3% | 10.4% |
Return vs Industry: CSURE-M exceeded the IL Pharmaceuticals industry which returned -17.7% over the past year.
Return vs Market: CSURE-M exceeded the IL Market which returned 8.3% over the past year.
Price Volatility
| CSURE-M volatility | |
|---|---|
| CSURE-M Average Weekly Movement | 13.1% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in IL Market | 8.4% |
| 10% least volatile stocks in IL Market | 3.1% |
Stable Share Price: CSURE-M's share price has been volatile over the past 3 months.
Volatility Over Time: CSURE-M's weekly volatility has decreased from 19% to 13% over the past year, but is still higher than 75% of IL stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | Ada Kama | cannassure.life |
Cannassure Therapeutics Ltd cultivates and produces medical cannabis. Its products comprise medical cannabis oils, indoor inflorescences, select inflorescences, value inflorescences, and cannavix. The company was founded in 2016 and is based in Ashdod, Israel.
Cannassure Therapeutics Ltd Fundamentals Summary
| CSURE-M fundamental statistics | |
|---|---|
| Market cap | ₪24.33m |
| Earnings (TTM) | -₪1.79m |
| Revenue (TTM) | ₪11.00m |
2.2x
P/S Ratio-13.6x
P/E RatioIs CSURE-M overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CSURE-M income statement (TTM) | |
|---|---|
| Revenue | ₪11.00m |
| Cost of Revenue | ₪7.81m |
| Gross Profit | ₪3.18m |
| Other Expenses | ₪4.97m |
| Earnings | -₪1.79m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.82 |
| Gross Margin | 28.95% |
| Net Profit Margin | -16.24% |
| Debt/Equity Ratio | 0% |
How did CSURE-M perform over the long term?
See historical performance and comparison